PubMed:15041272 / 385-705
Annnotations
TEST-DiseaseOrPhenotypicFeature
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T6 | 61-69 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
TEST-ChemicalEntity
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 16-19 | ChemicalEntity | denotes | PTT | http://purl.obolibrary.org/obo/CHEBI_3088 |
| T2 | 172-182 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 |
| T3 | 208-218 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 |
| T4 | 279-289 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 |
Test-GeneOrGeneProduct
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 24-38 | GeneOrGeneProduct | denotes | platelet count |
| T2 | 103-124 | GeneOrGeneProduct | denotes | von Willebrand factor |
| T3 | 249-253 | GeneOrGeneProduct | denotes | RIPA |
Test-merged-2
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T24079 | 16-19 | ChemicalEntity | denotes | PTT | http://purl.obolibrary.org/obo/CHEBI_3088 | |
| T38787 | 172-182 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 | |
| T27974 | 208-218 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 | |
| T50705 | 279-289 | ChemicalEntity | denotes | ristocetin | http://purl.obolibrary.org/obo/CHEBI_85129 | |
| T50816 | 24-38 | GeneOrGeneProduct | denotes | platelet count | ||
| T77624 | 103-124 | GeneOrGeneProduct | denotes | von Willebrand factor | ||
| T4499 | 249-253 | GeneOrGeneProduct | denotes | RIPA | ||
| T6 | 61-69 | DiseaseOrPhenotypicFeature | denotes | bleeding | D006470 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T5 | 0-320 | Sentence | denotes | In proband, PT, PTT and platelet count were normal; template bleeding time was 14 min; VIII:C was 51%, von Willebrand factor antigen (VWF:Ag), 42% and von Willerand factor ristocetin-cofactor (VWF:RCo, 15%); ristocetin-induced platelet aggregation (RIPA) at 0.3 and 0.6 mg/ml of ristocetin was 16% and 68%, respectively. |
| T5 | 0-320 | Sentence | denotes | In proband, PT, PTT and platelet count were normal; template bleeding time was 14 min; VIII:C was 51%, von Willebrand factor antigen (VWF:Ag), 42% and von Willerand factor ristocetin-cofactor (VWF:RCo, 15%); ristocetin-induced platelet aggregation (RIPA) at 0.3 and 0.6 mg/ml of ristocetin was 16% and 68%, respectively. |